Satoe Yokoyama
Hiroshima, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Real-world efficacy and safety of daclatasvir and asunaprevir therapy for hepatitis C virus-infected cirrhosis patients.
Journal: Journal of gastroenterology and hepatology
Published: August 07, 2016
Safety and efficacy of dual therapy with daclatasvir and asunaprevir for older patients with chronic hepatitis C.
Journal: Journal of gastroenterology
Published: May 29, 2016
Vitamin D supplementation on IFN-based therapy
Journal: Nihon rinsho. Japanese journal of clinical medicine
Published: February 06, 2016
Effects of ITPA polymorphism on decrease of hemoglobin during simeprevir, peg-interferon, and ribavirin combination treatment for chronic hepatitis C.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: August 20, 2015
Effect of prolonged administration of pegylated interferon/ribavirin therapy in genotypes 2a and 2b: propensity score-matched analysis.
Journal: Journal of gastroenterology and hepatology
Published: June 28, 2014
Interferon lambda 4 polymorphism affects on outcome of telaprevir, pegylated interferon and ribavirin combination therapy for chronic hepatitis C.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: December 31, 2013
Predictive value of the IFNL4 polymorphism on outcome of telaprevir, peginterferon, and ribavirin therapy for older patients with genotype 1b chronic hepatitis C.
Journal: Journal of gastroenterology
Published: September 27, 2013
Non-invasive liver fibrosis score calculated by combination of virtual touch tissue quantification and serum liver functional tests in chronic hepatitis C patients.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: December 07, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026